Royal Bank Of Canada Moderna, Inc. Put Options Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $225,150 - $305,007	1,900 New	1,900 $230,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $947,040 - $1.68 Million	-8,000 Reduced 22.22%	28,000 $5.03 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $12.6 Million - $23.5 Million	-100,000 Reduced 73.53%	36,000 $6.2 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $22.3 Million - $36.4 Million	98,700 Added 264.61%	136,000 $34.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $155,330 - $339,129	-700 Reduced 1.84%	37,300 $14.4 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $4.94 Million - $8.93 Million	38,000 New	38,000 $8.93 Million

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.9B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.